BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 29304493)

  • 1. MicroRNA-30c functions as a tumor suppressor via targeting SNAI1 in esophageal squamous cell carcinoma.
    Ma T; Zhao Y; Lu Q; Lu Y; Liu Z; Xue T; Shao Y
    Biomed Pharmacother; 2018 Feb; 98():680-686. PubMed ID: 29304493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-145 Inhibits Cell Migration and Invasion and Regulates Epithelial-Mesenchymal Transition (EMT) by Targeting Connective Tissue Growth Factor (CTGF) in Esophageal Squamous Cell Carcinoma.
    Han Q; Zhang HY; Zhong BL; Wang XJ; Zhang B; Chen H
    Med Sci Monit; 2016 Oct; 22():3925-3934. PubMed ID: 27771733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-218 inhibits the proliferation and metastasis of esophageal squamous cell carcinoma cells by targeting BMI1.
    Wang T; Chen T; Niu H; Li C; Xu C; Li Y; Huang R; Zhao J; Wu S
    Int J Mol Med; 2015 Jul; 36(1):93-102. PubMed ID: 25999024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-340 Inhibits Esophageal Cancer Cell Growth and Invasion by Targeting Phosphoserine Aminotransferase 1.
    Yan S; Jiang H; Fang S; Yin F; Wang Z; Jia Y; Sun X; Wu S; Jiang T; Mao A
    Cell Physiol Biochem; 2015; 37(1):375-86. PubMed ID: 26316084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-630 inhibits invasion and metastasis in esophageal squamous cell carcinoma.
    Jin L; Yi J; Gao Y; Han S; He Z; Chen L; Song H
    Acta Biochim Biophys Sin (Shanghai); 2016 Sep; 48(9):810-9. PubMed ID: 27563011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-143 inhibits tumor progression by targeting FAM83F in esophageal squamous cell carcinoma.
    Mao Y; Liu J; Zhang D; Li B
    Tumour Biol; 2016 Jul; 37(7):9009-22. PubMed ID: 26758433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. microRNA-27a functions as a tumor suppressor in esophageal squamous cell carcinoma by targeting KRAS.
    Zhu L; Wang Z; Fan Q; Wang R; Sun Y
    Oncol Rep; 2014 Jan; 31(1):280-6. PubMed ID: 24154848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
    Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
    J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor suppressor miR-128-3p inhibits metastasis and epithelial-mesenchymal transition by targeting ZEB1 in esophageal squamous-cell cancer.
    Zhao L; Li R; Xu S; Li Y; Zhao P; Dong W; Liu Z; Zhao Q; Tan B
    Acta Biochim Biophys Sin (Shanghai); 2018 Feb; 50(2):171-180. PubMed ID: 29329360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-143-3p functions as a tumor suppressor by regulating cell proliferation, invasion and epithelial-mesenchymal transition by targeting QKI-5 in esophageal squamous cell carcinoma.
    He Z; Yi J; Liu X; Chen J; Han S; Jin L; Chen L; Song H
    Mol Cancer; 2016 Jun; 15(1):51. PubMed ID: 27358073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-99a suppresses proliferation, migration and invasion of esophageal squamous cell carcinoma cells through inhibiting the IGF1R signaling pathway.
    Mei LL; Qiu YT; Huang MB; Wang WJ; Bai J; Shi ZZ
    Cancer Biomark; 2017 Dec; 20(4):527-537. PubMed ID: 28800315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of miR-429 on cell migration and invasion by targeting Slug in esophageal squamous cell carcinoma.
    Zong M; Liu Y; Zhang K; J Y; Chen L
    Pathol Res Pract; 2019 Sep; 215(9):152526. PubMed ID: 31324391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of miR-191 Predicts Poor Prognosis and Promotes Proliferation and Invasion in Esophageal Squamous Cell Carcinoma.
    Gao X; Xie Z; Wang Z; Cheng K; Liang K; Song Z
    Yonsei Med J; 2017 Nov; 58(6):1101-1110. PubMed ID: 29047233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA DDX11 antisense RNA 1 promotes EMT process of esophageal squamous cell carcinoma by sponging miR-30d-5p to regulate SNAI1/ZEB2 expression and Wnt/β-catenin pathway.
    Guo Y; Sun P; Guo W; Yin Q; Han J; Sheng S; Liang J; Dong Z
    Bioengineered; 2021 Dec; 12(2):11425-11440. PubMed ID: 34866524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-424-5p participates in esophageal squamous cell carcinoma invasion and metastasis via SMAD7 pathway mediated EMT.
    Wang F; Wang J; Yang X; Chen D; Wang L
    Diagn Pathol; 2016 Sep; 11(1):88. PubMed ID: 27628042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-150 is associated with poor prognosis in esophageal squamous cell carcinoma via targeting the EMT inducer ZEB1.
    Yokobori T; Suzuki S; Tanaka N; Inose T; Sohda M; Sano A; Sakai M; Nakajima M; Miyazaki T; Kato H; Kuwano H
    Cancer Sci; 2013 Jan; 104(1):48-54. PubMed ID: 23013135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-1290 promotes esophageal squamous cell carcinoma cell proliferation and metastasis.
    Li M; He XY; Zhang ZM; Li S; Ren LH; Cao RS; Feng YD; Ji YL; Zhao Y; Shi RH
    World J Gastroenterol; 2015 Mar; 21(11):3245-55. PubMed ID: 25805931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SQLE induces epithelial-to-mesenchymal transition by regulating of miR-133b in esophageal squamous cell carcinoma.
    Qin Y; Zhang Y; Tang Q; Jin L; Chen Y
    Acta Biochim Biophys Sin (Shanghai); 2017 Feb; 49(2):138-148. PubMed ID: 28069586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RACK1 predicts poor prognosis and regulates progression of esophageal squamous cell carcinoma through its epithelial-mesenchymal transition.
    Wang N; Liu F; Cao F; Jia Y; Wang J; Ma W; Tan B; Wang K; Song Q; Cheng Y
    Cancer Biol Ther; 2015; 16(4):528-40. PubMed ID: 25719728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulated miR-26a promotes proliferation, migration, and invasion
    Yang C; Zheng S; Liu T; Liu Q; Dai F; Zhou J; Chen Y; Sheyhidin I; Lu X
    FASEB J; 2017 May; 31(5):2114-2122. PubMed ID: 28174206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.